No Photo Available

Last Update

2016-12-06T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Siggi Olafsson?

Mr. Siggi O. Olafsson

Direct Phone: (215) ***-****       

Email: s***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Teva Pharmaceutical Industries Ltd.

5 Basel Street

Petah Tiqwa, Central District 4951033

Israel

Company Description

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world's larg ... more

Find other employees at this company (13,163)

Background Information

Employment History

Executive Vice President

Durata Therapeutics Inc

Education

M.S.

Pharmacy

University of Iceland

Web References (32 Total References)


Welcome to Pharmacloud Research

www.pharmacloud.co.uk [cached]

Siggi Olafsson

...
The news earlier this week that Siggi Olafsson is leaving Teva, to be succeeded by Dipankar Bhattacharjee (currently head of Teva Generics Europe) comes as something of a surprise, to say the least. As the architect of Teva's long drawn-out purchase of Allergan's generics business, Actavis, we would have expected him at least to ... Read More


The news earlier this week that ...

www.pharmacloud.co.uk [cached]

The news earlier this week that Siggi Olafsson is leaving Teva, to be succeeded by Dipankar Bhattacharjee (currently head of Teva Generics Europe) comes as something of a surprise, to say the least.

...
And the timing of the announcement is odd, given that Mr Olafsson hosted an investor day on New York in September at which he laid out the growth plan for the expanded Teva generics division, which he will now not be staying around to deliver. But of course, the deliverability of the plan may be precisely why he is going.


Teva (TEVA) Exec Departure Means 2017 Outlook Is Even More Crucial | Benzinga

feeds.benzinga.com [cached]

Bhattacharjee will replace Siggi Olafsson, who is to step down from his position at the end of Q1:17.

"Mr. Olafsson has led TEVA's global generic business since joining the company in 2014, and was instrumental in the acquisition of Actavis Generics (which he previously headed before joining TEVA)," Gilbert mentioned.


"This commercial partnership with ...

www.pipelinereview.com [cached]

"This commercial partnership with Celltrion enables Teva to expand into the upcoming wave of biosimilars and build on its strong position in the biosimilar space," said Siggi Olafsson, President & CEO of Global Generic Medicines, Teva Pharmaceuticals.


"This commercial partnership with ...

www.fiercebiotech.com [cached]

"This commercial partnership with Celltrion enables Teva to expand into the upcoming wave of biosimilars and build on its strong position in the biosimilar space," said Siggi Olafsson, president and CEO of global generic medicines at Teva.

Similar Profiles

Other People with this Name

Other people with the name Olafsson

Kristofer Olafsson
Radwell Communication

Brooke Olafsson
The Bureau of National Affairs , Inc.

Chris Olafsson
ReSound Corporation

Jason Olafsson
Custom Health Center

Anna Olafsson
L&T Infotech Limited

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory